Rubius Therapeutics
RUBY
#10516
Rank
$1.98 M
Marketcap
$0.02198
Share price
7.74%
Change (1 day)
-98.28%
Change (1 year)

Revenue for Rubius Therapeutics (RUBY)

Revenue in 2022 (TTM): N/A

In 2021 the company made a revenue of N/A a decrease over the revenue in the year 2020 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Rubius Therapeutics from 2017 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA